Centogene N v
Officers & Directors
1. Andrin Oswald: CEO 2. Richard Stoffelen: CFO 3. Volkmar Weckesser: CCO 4. Manfred Horst: CMO 5. Hannes Smarason: Executive Chairman Board of Directors: 1. Dr. Flemming Ornskov: Chairman of the Board 2. Dr. Richard Beargie: Board Member 3. Dr. Johannes Griss: Board Member 4. Dr. Carmen Adams: Board Member 5. Dr. Nayel Zaki: Board Member 6
Centogene N v currently has 400 employees.
News about Centogene N v Key Personnel |
CENTOGENE, a leading global provider of diagnostic and research solutions in rare diseases, has announced its successful accreditation for the French Research Tax Credit. This achievement allows CENTOGENE s partners to claim up to 30% tax relief, thereby providing significant financial advantages and promoting further collaboration in the field of medical research.
The company s year-to-date performance stands at an impressive 6.84%, reflecting CENTOGENE s commitment to leveraging innovative technologies and scientific expertise to make a meaningful impact on patients lives. The recent accreditation for the French Research Tax Credit adds another feather to their cap, exemplifying their contin...
|
Centogene N.V., a prominent life science company specializing in data-driven solutions for rare and neurodegenerative diseases, has recently released its preliminary unaudited revenue figures for the full year of 2023. The company s revenue for this period is estimated to be between approximately 48.5 million and 49.0 million, showcasing a growth rate in the mid-single digits compared to 2022.
Based in Cambridge, Massachusetts, as well as Rostock and Berlin in Germany, Centogene N.V. has established itself as a crucial partner in the field of rare and neurodegenerative diseases. By utilizing innovative technologies and cutting-edge analytics, the company provides essential answers to patients, ...
|
|
